Latest & greatest articles for osteoarthritis

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on osteoarthritis or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on osteoarthritis and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for osteoarthritis

501. Suprascapular nerve block reduced chronic shoulder pain and disability in degenerative disease or rheumatoid arthritis Full Text available with Trip Pro

Suprascapular nerve block reduced chronic shoulder pain and disability in degenerative disease or rheumatoid arthritis Suprascapular nerve block reduced chronic shoulder pain and disability in degenerative disease or rheumatoid arthritis | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your (...) username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Suprascapular nerve block reduced chronic shoulder pain and disability in degenerative disease or rheumatoid arthritis Article Text Therapeutics

2005 Evidence-Based Medicine

502. Artificial trapeziometacarpal joint replacement for end-stage osteoarthritis (IPG111)

of the fingers and thumb. Conservative treatments for osteoarthritis of the hand include anti-inflammatory and analgesic medication, and steroid injections. Other treatments for more severe disease include joint excision without replacement (excision arthroplasty), native graft arthroplasty (the patient's own tissue is interposed in the space left after joint excision) and fusion of the joint (arthrodesis). To insert an artificial TMC joint, a general anaesthetic is usually used and a tourniquet is applied (...) Artificial trapeziometacarpal joint replacement for end-stage osteoarthritis (IPG111) Overview | Artificial trapeziometacarpal joint replacement for end-stage osteoarthritis | Guidance | NICE Artificial trapeziometacarpal joint replacement for end-stage osteoarthritis Interventional procedures guidance [IPG111] Published date: February 2005 Share Save Guidance The National Institute for Health and Clinical Excellence (NICE) has issued full guidance to the NHS in England, Wales, Scotland

2005 National Institute for Health and Clinical Excellence - Interventional Procedures

503. Randomised controlled trial of the cost-effectiveness of water-based therapy for lower limb osteoarthritis

of the quality of this assessment has been made for the HTA database. Citation Cochrane T, Davey R C, Matthes Edwards S M. Randomised controlled trial of the cost-effectiveness of water-based therapy for lower limb osteoarthritis. Health Technology Assessment 2005; 9(31): 1 -130 Authors' objectives The aim of this report was to determine the efficacy of community water-based therapy for the management of lower limb osteoarthritis (OA) in older patients. Authors' conclusions Group-based exercise in water over (...) , from both a provider and a participant perspective, the societal costs of the different approaches to the management of OA and longer term trends in outcome measures (costs and effects). Project page URL INAHTA brief and checklist Indexing Status Subject indexing assigned by CRD MeSH Exercise Therapy; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Water Language Published English Country of organisation England Address for correspondence NETSCC, Health Technology Assessment, Alpha House

2005 Health Technology Assessment (HTA) Database.

504. Unicompartmental knee arthroplasty for unicompartmental osteoarthritis: a systematic review. Report no 44.

surrounding the treatment of osteoarthritis in the knee. The continuing contribution of data to national joint registries will aid in validating the current trends, particularly in knee survival after unicompartmental or total knee arthroplasty. Project page URL INAHTA brief and checklist Indexing Status Subject indexing assigned by CRD MeSH Arthroplasty, Replacement, Knee /methods; Osteoarthritis, Knee /surgery Language Published English Country of organisation Australia Address for correspondence PO Box (...) Unicompartmental knee arthroplasty for unicompartmental osteoarthritis: a systematic review. Report no 44. Unicompartmental knee arthroplasty for unicompartmental osteoarthritis: a systematic review. Report no 44. Unicompartmental knee arthroplasty for unicompartmental osteoarthritis: a systematic review. Report no 44. Australian Safety and Efficacy Register of New Interventional Procedures - Surgical Record Status This is a bibliographic record of a published health technology assessment from

2005 Health Technology Assessment (HTA) Database.

505. Celecoxib for the treatment of pain in osteoarthritis and rheumatoid arthritis

. Celecoxib for the treatment of pain in osteoarthritis and rheumatoid arthritis. Edmonton: Alberta Heritage Foundation for Medical Research (AHFMR). AHFMR - Information Paper #24. 2005 Authors' objectives The objective of this review was to present the current evidence on the efficacy/effectiveness and safety of celecoxib (Celebrex (R)) for the treatment of pain in patients with osteoarthritis (OA) and rheumatoid arthritis (RA). Authors' conclusions Overall, short-term use of celecoxib was equivalent (...) Celecoxib for the treatment of pain in osteoarthritis and rheumatoid arthritis Celecoxib for the treatment of pain in osteoarthritis and rheumatoid arthritis Celecoxib for the treatment of pain in osteoarthritis and rheumatoid arthritis Moga C, Harstall C, Tang Z Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Moga C, Harstall C, Tang Z

2005 Health Technology Assessment (HTA) Database.

506. Intra-articular viscosupplementation with hylan G-F 20 to treat osteoarthritis of the knee: an evidence-based analysis

of this assessment has been made for the HTA database. Citation Intra-articular viscosupplementation with hylan G-F 20 to treat osteoarthritis of the knee: an evidence-based analysis. Medical Advisory Secretariat (MAS). Volume 5(10). 2005 Authors' objectives The aim of this review was to assess the effectiveness and cost-effectiveness of hylan G-F 20 as a substitute for existing treatments for pain due to osteoarthritis (OA) of the knee, other viscosupplementation devices, and/or as an adjunct to conventional (...) considerable methodological limitations that result in uncertainty about the magnitude of effect. An upcoming review of the evidence by the Osteoarthritis Advisory Panel of clinical experts will likely help to reduce some of this uncertainty. There is moderate evidence that hylan G-F 20 is no more clinically effective than NSAIDs. The evidence that hylan G-F 20 may be an appropriate option for people with OA of the knee who cannot tolerate NSAIDs is indirect. The possible benefit of fewer cases of NSAID

2005 Health Technology Assessment (HTA) Database.

507. Technologies for osteoarthritis of the knee: an evidence-based analysis

Technologies for osteoarthritis of the knee: an evidence-based analysis Technologies for osteoarthritis of the knee: an evidence-based analysis Technologies for osteoarthritis of the knee: an evidence-based analysis Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Technologies for osteoarthritis of the knee: an evidence-based analysis (...) . Medical Advisory Secretariat (MAS). Volume 5(15). 2005 Authors' objectives The aim of this report was to review the treatment of osteoarthritis of the knee. Final publication URL Additional data URL Indexing Status Subject indexing assigned by CRD MeSH Debridement; Irrigation; Osteoarthritis, Knee /therapy Language Published English Country of organisation Canada Province or state Ontario English summary An English language summary is available. Address for correspondence Ontario Ministry of Health

2005 Health Technology Assessment (HTA) Database.

508. Special report: intra-articular hyaluronan for osteoarthritis of the knee

Special report: intra-articular hyaluronan for osteoarthritis of the knee Special report: intra-articular hyaluronan for osteoarthritis of the knee Special report: intra-articular hyaluronan for osteoarthritis of the knee BlueCross BlueShield Association Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. The BlueCross BlueShield Association Technology Evaluation Center (...) website ( ) includes the most recent 3 years of TEC Assessments. To request older reports, please use the “contact us” feature on the website. Citation BlueCross BlueShield Association. Special report: intra-articular hyaluronan for osteoarthritis of the knee. Chicago: BlueCross BlueShield Association (BCBS). TEC Assessment 19(17). 2005 Authors' objectives The purpose of this Special Report is to review the evidence on hyaluronan from the perspective of the prior TEC Assessment (1998) and the 3

2005 Health Technology Assessment (HTA) Database.

509. Artificial trapeziometacarpal joint replacement for end-stage osteoarthritis

Artificial trapeziometacarpal joint replacement for end-stage osteoarthritis Artificial trapeziometacarpal joint replacement for end-stage osteoarthritis Artificial trapeziometacarpal joint replacement for end-stage osteoarthritis National Institute for Clinical Excellence Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation National Institute for Clinical Excellence (...) . Artificial trapeziometacarpal joint replacement for end-stage osteoarthritis. London: National Institute for Clinical Excellence (NICE) 2005: 2 Authors' objectives This study aims to assess the current evidence on artificial trapeziometacarpal joint replacement for end-stage osteoarthritis. Authors' conclusions 1.1 Current evidence on the safety and efficacy of artificial trapeziometacarpal (TMC) joint replacement for end-stage osteoarthritis appears adequate to support the use of this procedure provided

2005 Health Technology Assessment (HTA) Database.

510. Aerobic walking or strengthening exercise for osteoarthritis of the knee: a systematic review

Aerobic walking or strengthening exercise for osteoarthritis of the knee: a systematic review Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2005 DARE.

511. Systematic review of therapies for osteoarthritis of the hand

Systematic review of therapies for osteoarthritis of the hand Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2005 DARE.

512. Intra-articular hyaluronic acid for the treatment of osteoarthritis of the knee: systematic review and meta-analysis

Intra-articular hyaluronic acid for the treatment of osteoarthritis of the knee: systematic review and meta-analysis Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2005 DARE.

513. Glucosamine long-term treatment and the progression of knee osteoarthritis: systematic review of randomized controlled trials

Glucosamine long-term treatment and the progression of knee osteoarthritis: systematic review of randomized controlled trials Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2005 DARE.

514. Pulsed electromagnetic field therapy and osteoarthritis of the knee: synthesis of the literature

of the individual trial results was provided and the difference between the intervention and control group was not clearly reported for all trials. This means that it is not possible to properly assess the conclusions. Authors' objectives To describe the results of efficacy studies on the application of therapeutic pulsed electromagnetic fields to patients with varying severity of knee joint osteoarthritis. Searching MEDLINE (1966 to 2005), EMBASE (1982 to 2005), AMED (1996 to 2005), and CINAHL (1966 to 2005 (...) ) databases were searched for articles in English. Study selection Randomised controlled trials (RCTs) assessing the effectiveness of the application of pulsed electromagnetic fields to knee joints with osteoarthritis were included in this review. The intervention characteristics varied widely across trials; session duration ranged from six minutes to one hour, the number of sessions ranged from eight to 84, and the frequency of administration ranged from three times daily to three-to-five times per week

2005 DARE.

515. Therapeutic knee taping improved pain and disability in osteoarthritis of the knee Full Text available with Trip Pro

and outcome assessors. Follow up period: 3 weeks each of intervention and follow up. Setting: metropolitan private practices and a university laboratory in Melbourne, Victoria, Australia. Patients: 87 patients (mean age 69 y, 66% women) who met the American College of Rheumatology criteria for OA of the knee. Exclusion criteria included allergy to tape, history of joint replacement, body mass index >38 kg/m 2 , and rheumatoid arthritis. Intervention: 29 patients each were allocated to TKT, control tape (...) Felson , MD, MPH Statistics from Altmetric.com Hinman RS, Crossley KM, McConnell J, et al . Efficacy of knee tape in the management of osteoarthritis of the knee: blinded randomised controlled trial. BMJ 2003 ; 327 : 135 –8. Q In patients with osteoarthritis (OA) of the knee, does therapeutic knee taping (TKT) reduce pain and disability? Clinical impact ratings GP/FP/Primary care ★★★★★★☆ Rheumatology ★★★★★☆☆ METHODS Design: randomised controlled trial. Allocation: not concealed. Blinding: patients

2005 Evidence-Based Medicine

516. Pathogenesis and management of pain in osteoarthritis. (Abstract)

Pathogenesis and management of pain in osteoarthritis. The term osteoarthritis describes a common, age-related, heterogeneous group of disorders characterised pathologically by focal areas of loss of articular cartilage in synovial joints, associated with varying degrees of osteophyte formation, subchondral bone change, and synovitis. Joint damage is caused by a mixture of systemic factors that predispose to the disease, and local mechanical factors that dictate its distribution and severity (...) . Various genetic abnormalities have been described, but most sporadic osteoarthritis probably depends on minor contributions from several genetic loci. Osteoarthritic joint damage may be associated with clinical problems, but the severity of joint disease is only weakly related to that of the clinical problem. For this reason the associations and pathogenesis of pain are in as much need of investigation as joint damage. Subchondral bone and synovium may be responsible for nociceptive stimuli

2005 Lancet

517. The clinical effectiveness and cost effectiveness of supplementing a home exercise programme with a class based exercise programme in the treatment of knee osteoarthritis Full Text available with Trip Pro

The clinical effectiveness and cost effectiveness of supplementing a home exercise programme with a class based exercise programme in the treatment of knee osteoarthritis Supplementation of a home-based exercise programme with a class-based programme for people with osteoarthritis of the knees: a randomised controlled trial and health economic analysis Journals Library An error has occurred in processing the XML document An error occurred retrieving content to display, please try again

2004 NIHR HTA programme

518. A topical cream containing glucosamine and chondroitin sulphate reduced joint pain in osteoarthritis of the knee Full Text available with Trip Pro

A topical cream containing glucosamine and chondroitin sulphate reduced joint pain in osteoarthritis of the knee A topical cream containing glucosamine and chondroitin sulphate reduced joint pain in osteoarthritis of the knee | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username (...) and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here A topical cream containing glucosamine and chondroitin sulphate reduced joint pain in osteoarthritis of the knee Article Text Therapeutics A topical cream containing

2004 Evidence-Based Medicine

519. Acupuncture as a complementary therapy to the pharmacological treatment of osteoarthritis of the knee: randomised controlled trial. Full Text available with Trip Pro

Acupuncture as a complementary therapy to the pharmacological treatment of osteoarthritis of the knee: randomised controlled trial. To analyse the efficacy of acupuncture as a complementary therapy to the pharmacological treatment of osteoarthritis of the knee, with respect to pain relief, reduction of stiffness, and increased physical function during treatment; modifications in the consumption of diclofenac during treatment; and changes in the patient's quality of life.Randomised, controlled (...) , single blind trial, with blinded evaluation and statistical analysis of results.Pain management unit in a public primary care centre in southern Spain, over a period of two years.97 outpatients presenting with osteoarthritis of the knee.Patients were randomly separated into two groups, one receiving acupuncture plus diclofenac (n = 48) and the other placebo acupuncture plus diclofenac (n = 49).The clinical variables examined included intensity of pain as measured by a visual analogue scale; pain

2004 BMJ Controlled trial quality: predicted high

520. Randomised controlled trial of magnetic bracelets for relieving pain in osteoarthritis of the hip and knee. Full Text available with Trip Pro

Randomised controlled trial of magnetic bracelets for relieving pain in osteoarthritis of the hip and knee. To determine the effectiveness of commercially available magnetic bracelets for pain control in osteoarthritis of the hip and knee.Randomised, placebo controlled trial with three parallel groups.Five rural general practices.194 men and women aged 45-80 years with osteoarthritis of the hip or knee.Wearing a standard strength static bipolar magnetic bracelet, a weak magnetic bracelet (...) , or a non-magnetic (dummy) bracelet for 12 weeks.Change in the Western Ontario and McMaster Universities osteoarthritis lower limb pain scale (WOMAC A) after 12 weeks, with the primary comparison between the standard and dummy groups. Secondary outcomes included changes in WOMAC B and C scales and a visual analogue scale for pain.Mean pain scores were reduced more in the standard magnet group than in the dummy group (mean difference 1.3 points, 95% confidence interval 0.05 to 2.55). Self reported

2004 BMJ Controlled trial quality: predicted high